Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina
Background: Although test strips for self-monitoring of blood glucose (SMBG) represent around 50% of diabetes treatment cost in Argentina, little is known about their current use and relationship with different types of treatment. We therefore aimed to estimate the current use of test strips and ide...
| Autores: | , , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versão publicada |
| Data de publicação: | 2014 |
| País: | Argentina |
| Recursos: | Consejo Nacional de Investigaciones Científicas y Técnicas |
| Repositório: | CONICET Digital (CONICET) |
| Idioma: | inglês |
| OAI Identifier: | oai:ri.conicet.gov.ar:11336/33459 |
| Acesso em linha: | http://hdl.handle.net/11336/33459 |
| Access Level: | Acceso aberto |
| Palavra-chave: | Prescription Audit Self-Monitoring Blood Glucose Self-Monitoring Blood Glucose Relative Cost Type 2 Diabetes Treatment https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| id |
AR_19d702de4e00b1cde79f772ee41cd40a |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/33459 |
| network_acronym_str |
AR |
| network_name_str |
Argentina |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina |
| title |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina |
| spellingShingle |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina Elgart, Jorge Federico Prescription Audit Self-Monitoring Blood Glucose Self-Monitoring Blood Glucose Relative Cost Type 2 Diabetes Treatment https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| title_short |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina |
| title_full |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina |
| title_fullStr |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina |
| title_full_unstemmed |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina |
| title_sort |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina |
| dc.creator.none.fl_str_mv |
Elgart, Jorge Federico Gonzalez, Lorena Rucci, Enzo Gagliardino, Juan Jose |
| author |
Elgart, Jorge Federico |
| author_facet |
Elgart, Jorge Federico Gonzalez, Lorena Rucci, Enzo Gagliardino, Juan Jose |
| author_role |
author |
| author2 |
Gonzalez, Lorena Rucci, Enzo Gagliardino, Juan Jose |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
Prescription Audit Self-Monitoring Blood Glucose Self-Monitoring Blood Glucose Relative Cost Type 2 Diabetes Treatment https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| topic |
Prescription Audit Self-Monitoring Blood Glucose Self-Monitoring Blood Glucose Relative Cost Type 2 Diabetes Treatment https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| description |
Background: Although test strips for self-monitoring of blood glucose (SMBG) represent around 50% of diabetes treatment cost in Argentina, little is known about their current use and relationship with different types of treatment. We therefore aimed to estimate the current use of test strips and identify the major use drivers and the percentage they represent of total prescription costs in 2 entities of the social security system (SSS) of Argentina. Methods: Observational retrospective study measuring test strip prescriptions delivered by pharmacies from the province of Buenos Aires (8115 records collected during 3 months provided by the Colegio de Farmacéuticos de la Provincia de Buenos Aires) of affiliates with type 2 diabetes (T2DM) from 2 large entities of the SSS system. Results: The average monthly test strips/patient used for SMBG was 97.5 ± 70.1. This number varied according to treatment: monotherapy with oral antidiabetic drugs (OAD) < combined OAD therapy < insulin treatment. Test strips represented a higher percentage of the total prescription cost in people under OAD monotherapy (84.6%) and lower in those with insulin analogs (46.9%). Conclusions: In our population, the type of hyperglycemia treatment was the main driver of test strip use for SMBG and its impact on the total prescription cost depends on the kind of such treatment. Since it has been shown that patients’ education and prescription audit can optimize test strip use and treatment outcomes, implementation of such strategies could appropriately support, optimize, and reduce ineffective test strip use in people with T2DM. |
| publishDate |
2014 |
| dc.date.none.fl_str_mv |
2014-11 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/33459 Elgart, Jorge Federico; Gonzalez, Lorena; Rucci, Enzo; Gagliardino, Juan Jose; Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina; Wiley; Journal of Diabetes Science and Technology; 8; 11-2014; 1121-1125 1932-2968 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/33459 |
| identifier_str_mv |
Elgart, Jorge Federico; Gonzalez, Lorena; Rucci, Enzo; Gagliardino, Juan Jose; Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina; Wiley; Journal of Diabetes Science and Technology; 8; 11-2014; 1121-1125 1932-2968 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/1932296814549993 info:eu-repo/semantics/altIdentifier/doi/10.1177/1932296814549993 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Wiley |
| publisher.none.fl_str_mv |
Wiley |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1799196171811422208 |
| spelling |
Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in ArgentinaElgart, Jorge FedericoGonzalez, LorenaRucci, EnzoGagliardino, Juan JosePrescription AuditSelf-Monitoring Blood GlucoseSelf-Monitoring Blood Glucose Relative CostType 2 Diabetes Treatmenthttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: Although test strips for self-monitoring of blood glucose (SMBG) represent around 50% of diabetes treatment cost in Argentina, little is known about their current use and relationship with different types of treatment. We therefore aimed to estimate the current use of test strips and identify the major use drivers and the percentage they represent of total prescription costs in 2 entities of the social security system (SSS) of Argentina. Methods: Observational retrospective study measuring test strip prescriptions delivered by pharmacies from the province of Buenos Aires (8115 records collected during 3 months provided by the Colegio de Farmacéuticos de la Provincia de Buenos Aires) of affiliates with type 2 diabetes (T2DM) from 2 large entities of the SSS system. Results: The average monthly test strips/patient used for SMBG was 97.5 ± 70.1. This number varied according to treatment: monotherapy with oral antidiabetic drugs (OAD) < combined OAD therapy < insulin treatment. Test strips represented a higher percentage of the total prescription cost in people under OAD monotherapy (84.6%) and lower in those with insulin analogs (46.9%). Conclusions: In our population, the type of hyperglycemia treatment was the main driver of test strip use for SMBG and its impact on the total prescription cost depends on the kind of such treatment. Since it has been shown that patients’ education and prescription audit can optimize test strip use and treatment outcomes, implementation of such strategies could appropriately support, optimize, and reduce ineffective test strip use in people with T2DM.Fil: Elgart, Jorge Federico. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de la Plata. Facultad de Cs.médicas. Centro de Endocrinología Experimental y Aplicada; ArgentinaFil: Gonzalez, Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de la Plata. Facultad de Cs.médicas. Centro de Endocrinología Experimental y Aplicada; ArgentinaFil: Rucci, Enzo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de la Plata. Facultad de Cs.médicas. Centro de Endocrinología Experimental y Aplicada; ArgentinaFil: Gagliardino, Juan Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de la Plata. Facultad de Cs.médicas. Centro de Endocrinología Experimental y Aplicada; ArgentinaWiley2014-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/33459Elgart, Jorge Federico; Gonzalez, Lorena; Rucci, Enzo; Gagliardino, Juan Jose; Self-Monitoring of Blood Glucose: Use, Frequency Drivers, and Cost in Argentina; Wiley; Journal of Diabetes Science and Technology; 8; 11-2014; 1121-11251932-2968CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/1932296814549993info:eu-repo/semantics/altIdentifier/doi/10.1177/1932296814549993info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2024-05-08T14:17:24Zoai:ri.conicet.gov.ar:11336/33459instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982024-05-08 14:17:24.256CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| score |
15.812455 |